Scopus
YÖKSİS Eşleşti
CANCER RISK ESTIMATION for PATIENTS UNDERGOING WHOLE-BODY PET/CT SCANS
Radiation Protection Dosimetry · Nisan 2023
YÖKSİS Kayıtları
Cancer risk estimation for patients undergoing whole-body PET/CT scans
Radiation Protection Dosimetry · 2023 SCI-Expanded
PROFESÖR NİHAL BÜYÜKÇİZMECİ →
Makale Bilgileri
DergiRadiation Protection Dosimetry
Yayın TarihiNisan 2023
Cilt / Sayfa199 · 509-518
Scopus ID2-s2.0-85152975876
Özet
The objective of this paper was to compute the effective dose, as well as the lifetime attributable risk (LAR) of cancer related to whole-body positron emission tomography (PET)/computed tomography (CT) scan for 193 adult patients. The mean effective dose for all patients from a single PET/CT scan was 20.6 mSv. For males aged 40 y, a single PET/CT scan is associated with a LAR of cancer incidence of 0.169%. This risk increased to 0.85% if an annual surveillance protocol for 5 y was performed. For female patients aged 40 y, the LAR of cancer mortality increased from 0.126 to 0.63% if an annual surveillance protocol for 5 y was performed. Since PET/CT scans are associated with a high dose and a risk of developing cancer, it was important to balance the advantages and risks before conducting any scans. This is especially important for younger patients and those who are overweight.
Yazarlar (3)
1
Aida Kessara
ORCID: 0000-0003-2479-7045
2
Nihal Buyukcizmeci
3
G. K. Gedik
Kurumlar
Selçuk Üniversitesi
Selçuklu Turkey
Metrikler
1
Atıf
3
Yazar